Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Sales | 11,848,000 | 12,870,000 | 11,990,000 | 11,084,000 | 12,474,000 |
| Cost of Goods | 1,986,000 | 2,625,000 | 4,618,000 | 2,109,000 | 1,887,000 |
| Gross Profit | 9,862,000 | 10,245,000 | 7,372,000 | 8,975,000 | 10,587,000 |
| Operating Expenses | 6,638,000 | 7,885,000 | 6,996,000 | 7,843,000 | 6,936,000 |
| Operating Income | 3,224,000 | 2,360,000 | 376,000 | 1,132,000 | 3,651,000 |
| Other Income | 333,000 | 610,000 | 260,000 | 487,000 | 402,000 |
| Pre-tax Income | 3,557,000 | 2,970,000 | 636,000 | 1,619,000 | 4,053,000 |
| Income Tax | 763,000 | 223,000 | -161,000 | 272,000 | 689,000 |
| Net Income Continuous | 2,794,000 | 2,753,000 | 796,000 | 1,345,000 | 3,361,000 |
| Net Income Discontinuous | -4,000 | 13,000 | -35,000 | -78,000 | 31,000 |
| Minority Interests | 6,000 | N/A | N/A | N/A | N/A |
| Net Income | $2,784,000 | $2,724,000 | $761,000 | $1,267,000 | $3,392,000 |
| EPS Basic Total Ops | 0.41 | 0.41 | 0.11 | 0.18 | 0.48 |
| EPS Basic Continuous Ops | 0.41 | 0.40 | 0.12 | 0.19 | 0.48 |
| EPS Basic Discontinuous Ops | 0.00 | 0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted Total Ops | 0.41 | 0.40 | 0.11 | 0.18 | 0.48 |
| EPS Diluted Continuous Ops | 0.41 | 0.39 | 0.12 | 0.19 | 0.48 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.01 | -0.01 | -0.01 | 0.00 |
| EBITDA(a) | $4,711,000 | $3,476,000 | $1,748,000 | $2,573,000 | $4,922,000 |